Cannabis Medicines

Policy information

  • IB2019_041 Schedule 8 Cannabis Medicines and Unregistered Schedule 8 Medicines Information Bulletin. NSW Health. 16 October 2019.
  • NSW-based clinicians should obtain information tailored to the patient-specific clinical context from the NSW Cannabis Medicines Advisory Service (NSW CMAS) including, but not limited to, clinical and scientific evidence and clinical trials.
  • Information on NSW-based regulatory requirements for prescription and supply of S8 Cannabis Medicines, including prescriber, dispensing and storage requirements is available from NSW Ministry of Health Pharmaceutical Services.


Other online resources



Page last updated 4 February 2021